Your browser doesn't support javascript.
loading
A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells.
Liu, Yang; Jie, Xingxing; Nian, Li; Wang, Ying; Wang, Congyue; Ma, Jin; Jiang, Jingjing; Wu, Qingyun; Qiao, Jianlin; Chen, Wei; Cao, Jiang; Yan, Zhiling; Shi, Ming; Cheng, Hai; Zhu, Feng; Sang, Wei; Li, Depeng; Chen, Chong; Xu, Kailin; Li, Zhenyu.
Afiliación
  • Liu Y; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Jie X; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Nian L; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China.
  • Wang Y; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Wang C; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Ma J; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China.
  • Jiang J; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Wu Q; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Qiao J; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China.
  • Chen W; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Cao J; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Yan Z; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China.
  • Shi M; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Cheng H; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Zhu F; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China.
  • Sang W; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Li D; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Chen C; Jiangsu Key Laboratory of Bone Marrow Stem Cells, Xuzhou, Jiangsu, China.
  • Xu K; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Li Z; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Front Immunol ; 14: 1169071, 2023.
Article en En | MEDLINE | ID: mdl-37153543
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Mieloma Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Mieloma Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: China